期刊文献+

VEGFR-2酪氨酸激酶抑制剂的三维定量构效关系研究 被引量:4

Three Dimensional Quantitative Structure Activity Relationship of VEGFR-2 Tyrosine Kinase Inhibitors
下载PDF
导出
摘要 运用比较分子力场分析对28个氨基吡唑并吡啶二芳基脲类VEGFR-2酪氨酸激酶抑制剂进行了三维定量构效关系研究。所得CoMFA模型交叉验证系数q2=0.681,回归系数r2=0.958,统计方差比F=64.964,影响药效的立体场和静电场的贡献分别为65.7%和34.3%。CoMFA模型的三维等值图为化合物的结构改造提供了参考。 The three dimensional structure activity relationship was studied on a series of aminopyrazolopyridine diaryl urea VEGFR-2 tyrosine kinase inhibitors by comparative molecular field analysis (CoM- FA). The results indiated that the CoMFA model had a cross validated coefficient q^2 of 0. 681 and the relation non-cross validated coefficient r^2 of 0. 958. The F value was 64. 964. The contributions of steric and electrostatic fields to the activity were 65.7% and 34.3% , respectively. The CoMFA model gave the basis on the structure modification of aminopyrazolopyridine diaryl urea VEGFR-2 tyrosine kinase inhibitors.
出处 《中山大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第1期57-61,共5页 Acta Scientiarum Naturalium Universitatis Sunyatseni
基金 广州市粤港关键领域重点突破资助项目(2006z1-E6021)
关键词 三维定量构效关系 比较分子力场分析 氨基吡唑并吡啶二芳基脲类 VEGFR-2酪氨酸激酶抑制剂 three dimensional quantitative structure activity relationship (3D-QSAR) comparative molecular field analysis (CoMFA) aminopyrazolopyridine diaryl urea VEGFR-2 tyrosine kinase inhibitors
  • 相关文献

参考文献10

  • 1GUO P, XU L, PAN S, et al. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites [J].Cancer Res, 2001, 61 (23) :8569 -8577.
  • 2FERRARA N, DAVIS-SMYTH T. The biology of vascular endothelial growth factor[ J]. Endocr Rev, 1997, 18 (1) : 4-25.
  • 3SHINKARUK S, BAYLE M, LAIN G, et al. Vascular endothelial cell growth factor (VEGF) , an emerging target for cancer chemotherapy [J]. Curr Med Chem Anti Cancer Agents, 2003, 3(2) :95 - 117.
  • 4CROSS M J, DIXELIUS J, MATSUMOTO T, et al. VEGF-receptor signal transduction [ J ]. Trends Biochem Sei, 2003, 28 : 488 -494.
  • 5茆勇军,张佩璇,田广辉,王震,沈敬山.血管内皮生长因子受体酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2008,17(7):544-550. 被引量:6
  • 6JI Z Q, AHMED A A, ALBERT D H, et al. 3-Aminobenzo[ d ] isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases [ J ]. J Med Chem, 2008,51 : 1231 - 1241.
  • 7DAI Y J, HARTANDI K, JI Z Q, et al. Discovery of N- (4- (3-amino-1H-indazol-4-yl) phenyl) -N ' - ( 2-fluoro-5- methylphenyl ) urea ( ABT-869 ) , a 3-aminoindazole- based orally active muhitargeted receptor tyrosinekinase inhibitor[J]. J Med Chem, 2007, 50: 1584- 1597.
  • 8DAI Y, HARTANDI K, SONI N B, et al. Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR muhitargeted kinase inhibitors [ J ]. Bioorg Med Chem Lett, 2008, 18:386-390.
  • 9CRAMER R D, PATTERSON D E, BUNCE J D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins[ J]. J Am Chem Soc, 1988, 110:5959-5967.
  • 10MIYAZAKI Y, MATSUNAGA S, TANG J, et al. Novel 4-amino-furo[2,3-d] pyrimidines as Tie-2 and VEGFR2 dual inhibitors[ J]. Bioorg Med Chem Lett, 2005,15 : 2203 - 2207.

二级参考文献31

  • 1钟毅,李志裕,尤启冬.血管内皮细胞生长因子受体酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2006,15(3):181-185. 被引量:8
  • 2SEBOLT-LEOPOLD JS, ENGLISH JM. Mechanisms of drug inhibition of signalling molecules[J]. Nature, 2006, 441 (7092) : 457 - 462.
  • 3SHAW RJ, CANTLEY LC. Ras, PI(3)K and mTOR signaling controls tumour cell growth [ J ]. Nature, 2006, 441 (7092) : 424 - 430.
  • 4LIEBMANN C. Regulation of MAP kinase activity by peptide receptor signalling pathway : paradigms of multiplicity [ J ]. Cell Signal, 2001, 13(11) : 777 -785.
  • 5MARTELLI AM, TAZZARI PL, EVANGELISTI C, et al. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside[J]. Curr Med Chem, 2007, 14(19) : 2009 - 2023.
  • 6SUMMY JM, GALLICK GE. Treatment for advanced tumors: SRC reclaims center stage[J]. Clin Cancer Res, 2006, 12(5 ) : 1398 - 1401.
  • 7TABERNERO J. The role of VEGF and EGFR inhibition : implications for combining anti-VEGF and anti-EGFR agents[ J]. Mol Cancer Res, 2007, 5 (3) : 203 - 220.
  • 8Pharmaprojects V5 [ DB/OL ]. [ 2007 - 12 - 30 ]. http ://203. 156. 214. 150/citrix/nfuse17/frameset. asp.
  • 9MORABITO A, DE MAIO E, DI MAIO M, et al. Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions [ J ]. Oncologist, 2006, 11(7): 753-764.
  • 10MOTZER RJ, MICHAELSON MD, REDMAN BG, et al. Activity of SU11248, a muhitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma[ J ]. J Clin Oncol, 2006, 24(1): 16-24.

共引文献5

同被引文献48

  • 1熊筱娟,陈武,肖小华,徐丽英,崔江龙.乌索酸与齐墩果酸对小鼠实验性肝损伤保护作用的比较[J].江西师范大学学报(自然科学版),2004,28(6):540-543. 被引量:30
  • 2潘萍,孙启时.大叶紫珠的化学成分[J].沈阳药科大学学报,2006,23(9):565-567. 被引量:32
  • 3陈军,盛春泉,郑灿辉,李耀武,吕加国,张万年,周有骏,朱驹.VEGFR2活性腔性质以及与抑制剂的结合模式研究[J].化学学报,2007,65(6):547-552. 被引量:8
  • 4唐建生.激酶抑制剂的计算机辅助设计[J].化学通报,2007,70(6):471-475. 被引量:1
  • 5WEDEMEYER W J, WELKER E, NARAYAN M, et al. Disulfide bonds and protein folding [ J ]. Biochemistry, 2000, 39(15) :4207 -4216.
  • 6JI W R, CASTELLINO F J, CHANG Y, et al. Charac- terization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in an- giogenesis EJ]. FASEB J, 1998, 12(15) :1731 - 1738.
  • 7GAO G, LI Y, GEE S,et al. Down-regulation of vascular endothelial growth factor and up-regulation of pigment ep- ithelium-derived factor: a possible mechanism for the an- ti-angiogenic activity of plasminogen kringle 5 [ J ]. J Biol Chem, 2002, 277( 11 ) :9492 -9497.
  • 8YANG X, CHENG R, LI C, et al. Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity [ J]. Cancer Biol Ther, 2006, 5 (4) :399 - 405.
  • 9CAI W, MA J, LI C, et al. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization [ J ]. J Cell Biochem, 2005, 96 (6) : 1254 - 1261.
  • 10COX M, SCHALLER J, BOELENS R, et al. Kringle so- lution structures via NMR: two-dimensional 1H-NMR a- nalysis of horse plasminogen kringle 4 [ J ]. Chem Phys Lipids, 1994, 67 -68:43 -58.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部